Internal Medicine, Cardiovascular Disease · Meridian, MS
NPI
1164409710
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1600 22nd Ave, Medical Towers III
Meridian, MS, 39301
Phone (601) 483-5322
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
15,704 services
Medicare patients, 2024
1,691
Average age 75
Drug cost, 2024
$1.3M
11,433 prescriptions
Company payments, 2025
$404
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edwin M Purvis was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,733 times for 907 patients. In total Edwin M Purvis billed 15,704 services in 100 codes, and Medicare paid $1.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-02.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,733 | 907 | $11.89 | $21K |
| 93000 Electrocardiogram | Office | 1,728 | 1,094 | $9.78 | $17K |
| 99214 Office E&M - Established | Office | 1,494 | 797 | $85.34 | $127K |
| 80053 Clinical Chemistry | Office | 1,173 | 725 | $10.26 | $12K |
| 83735 Clinical Chemistry | Office | 1,167 | 725 | $6.51 | $7,600 |
| 80061 Clinical Chemistry | Office | 1,148 | 721 | $13.03 | $15K |
| 85027 Blood Count | Office | 937 | 622 | $6.30 | $5,907 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 728 | 182 | $5.48 | $3,990 |
| 93010 Electrocardiogram | Facility | 539 | 427 | $5.51 | $2,972 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 400 | 38 | $43.53 | $17K |
| 93296 External Electrocardiographic Monitoring | Office | 343 | 112 | $13.17 | $4,516 |
| 83036 Blood Count | Office | 290 | 194 | $9.50 | $2,754 |
| 84443 Clinical Chemistry | Office | 273 | 194 | $16.42 | $4,483 |
| 93294 External Electrocardiographic Monitoring | Office | 271 | 89 | $19.95 | $5,406 |
| 84439 Clinical Chemistry | Office | 269 | 191 | $8.82 | $2,372 |
By year: 2022 $767K for 14,267 services; 2023 $701K for 14,060 services; 2024 $1.0M for 15,704 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 1,173 | 725 | $10.26 | $12K |
| 83735 Clinical Chemistry | 1,167 | 725 | $6.51 | $7,600 |
| 80061 Clinical Chemistry | 1,148 | 721 | $13.03 | $15K |
| 85027 Blood Count | 937 | 622 | $6.30 | $5,907 |
| 83036 Blood Count | 290 | 194 | $9.50 | $2,754 |
| 84443 Clinical Chemistry | 273 | 194 | $16.42 | $4,483 |
| 84439 Clinical Chemistry | 269 | 191 | $8.82 | $2,372 |
| 82306 Clinical Chemistry | 98 | 91 | $29.01 | $2,843 |
| 36415 Venipuncture Blood Collection | 39 | 34 | $8.65 | $337 |
| 80048 Clinical Chemistry | 32 | 31 | $8.12 | $260 |
Medicare prescription drug claims, 2024
In 2024, the drug Edwin M Purvis prescribed most often to Medicare patients was Carvedilol, with 892 prescriptions and refills. In total Edwin M Purvis wrote 11,433 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carvedilol Generic | 892 | 2,451 | 277 | $6,608 |
| Eliquis Apixaban | 832 | 1,292 | 176 | $742K |
| Rosuvastatin Calcium Generic | 727 | 2,002 | 243 | $10K |
| Nifedipine Er Nifedipine | 620 | 1,700 | 202 | $16K |
| Atorvastatin Calcium Generic | 604 | 1,715 | 192 | $6,175 |
| Spironolactone Generic | 499 | 1,337 | 148 | $4,902 |
| Olmesartan Medoxomil Generic | 427 | 1,155 | 137 | $7,697 |
| Clopidogrel Clopidogrel Bisulfate | 426 | 1,209 | 129 | $4,661 |
| Metoprolol Succinate Generic | 387 | 1,067 | 125 | $6,262 |
| Amlodipine Besylate Generic | 366 | 1,054 | 127 | $1,949 |
| Losartan Potassium Generic | 356 | 994 | 107 | $3,142 |
| Potassium Chloride Generic | 324 | 865 | 104 | $8,416 |
| Furosemide Generic | 321 | 844 | 105 | $1,832 |
| Irbesartan Generic | 246 | 702 | 74 | $5,982 |
| Lisinopril Generic | 237 | 676 | 80 | $1,937 |
Brand drugs: 1,459 claims; generic drugs: 9,918 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edwin M Purvis $404 ($404 in general payments such as food, travel and fees) from 4 companies. The largest payer was Medtronic, Inc. with $314.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.